HomeATXS • NASDAQ
add
Astria Therapeutics Inc
Previous close
$10.55
Day range
$10.43 - $10.87
Year range
$4.26 - $16.90
Market cap
578.68M USD
Avg Volume
1.28M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 19.00M | 32.96% |
Net income | -31.41M | -136.82% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 246.53M | 8.87% |
Total assets | 254.67M | 10.42% |
Total liabilities | 11.55M | 22.65% |
Total equity | 243.12M | — |
Shares outstanding | 54.90M | — |
Price to book | 2.93 | — |
Return on assets | -21.18% | — |
Return on capital | -22.17% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -31.41M | -136.82% |
Cash from operations | -30.24M | -183.55% |
Cash from investing | -2.02M | 98.51% |
Cash from financing | 87.98M | -26.93% |
Net change in cash | 55.72M | 318.98% |
Free cash flow | -9.25M | -100.44% |
About
Founded
2008
Headquarters
Website
Employees
59